Liraglutide studies: 1,219 papers with results
Page 13 of 25
- Lean Mass Changes With Incretin Therapy Versus Lifestyle Intervention: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Eisa N · Diabetes, obesity & metabolism · 2026
Systematic review · 5 results
- Efficacy and safety of glucagon-like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials.
Yeo D · Diabetes, obesity & metabolism · 2026
Systematic review · 14 results
- Effect of glucagon-like peptide 1 receptor agonists on systolic blood pressure in patients with obesity, with or without diabetes: A systematic review and network meta-analysis.
Ali A · Clinical obesity · 2025
Systematic review · 8 results
- Comparative efficacy and safety of antidiabetic agents in Alzheimer's disease: A network meta-analysis of randomized controlled trials.
Cai Z · The journal of prevention of Alzheimer's disease · 2025
Systematic review · 1 result
- Association of long-term weight management pharmacotherapy with multiple health outcomes: an umbrella review and evidence map.
Lu TT · International journal of obesity (2005) · 2025
Systematic review · 35 results
- Meta-analysis of the clinical efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease.
Xu YY · Endocrine journal · 2024
Systematic review · 5 results
- Once-daily liraglutide (1.2 mg) compared with twice-daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta-analysis.
Twigg SM · Journal of diabetes · 2016
Systematic review · 6 results
- Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review.
Rico-Fontalvo J · Diabetes therapy : research, treatment and education of diabetes and related disorders · 2026
Systematic review · 9 results
- Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists Use in Elderly People With Obesity-A Meta-Analysis.
Rego de Figueiredo I · Obesity (Silver Spring, Md.) · 2026
Systematic review · 8 results
- Effectiveness of GLP-1 RAs and SGLT2 inhibitors in preventing T2DM in high-risk patients: an updated systematic review and meta-analysis.
Tsironikos GI · Frontiers in clinical diabetes and healthcare · 2025
Systematic review · 17 results
- Quantitative analysis of the efficacy characteristics and influencing factors of weight loss drugs in children and adolescents.
Wang Y · Diabetes, obesity & metabolism · 2025
Systematic review · 12 results
- Efficacy and Safety of Pharmacological Interventions in Managing Cardiometabolic Risk Factors in Youth Living with Overweight and Obesity: A Systematic Review and Network Meta-Analysis.
Faghfouri AH · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
Systematic review · 3 results
- Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review.
Masson R · Journal of drugs in dermatology : JDD · 2023
Systematic review · 1 result
- Pharmacotherapy for Children and Adolescents With Overweight or Obesity: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Luo L · Diabetes, obesity & metabolism · 2026
Systematic review · 7 results
- Comparative Effects of Antidiabetic Drugs on Body Composition: A Systematic Review and Network Meta-Analysis.
Rakhsha SS · Diabetes, obesity & metabolism · 2026
Systematic review · 6 results
- Weight Loss With GLP-1 Agonists in Nondiabetic Adults: Systematic Review and Network Meta-Analysis.
Lim M · Obesity (Silver Spring, Md.) · 2026
Systematic review · 9 results
- Effect of glucagon-like peptide-1 receptor agonists on heart rate in non-diabetic individuals with overweight or obesity: a systematic review and pairwise and network meta-analysis of randomized controlled trials.
Zhang Y · European journal of medical research · 2026
Systematic review · 10 results
- Effectiveness of GLP-1 RAs in Restoring Normoglycemia in Patients With Prediabetes: An Updated Systematic Review and Meta-Analysis.
Tsironikos GI · Diabetes/metabolism research and reviews · 2026
Systematic review · 15 results
- The safety and efficacy of liraglutide combined with metformin in clinical treatment of polycystic ovary syndrome patients: a meta-analysis.
Huang R · BMC women's health · 2025
Systematic review · 8 results
- Obesity medications in patients with recurrent weight gain or suboptimal clinical response following bariatric surgery: a meta-analysis.
Golzarand M · International journal of obesity (2005) · 2025
Systematic review · 2 results
- Effects of new hypoglycemic drugs on patients with heart failure: a systematic review and network meta-analysis.
Song R · Postgraduate medical journal · 2025
Systematic review · 5 results
- Network meta-analysis of the risk of dyspepsia and anorexia in patients with type 2 diabetes mellitus induced by glucagon-like peptide 1 receptor agonist hypoglycemic drugs.
Jiao BL · European review for medical and pharmacological sciences · 2024
Systematic review · 4 results
- GLP-1 Receptor Agonists and Musculoskeletal Outcomes: A Systematic Literature Review and Meta-Analysis.
Beaudart C · Drugs · 2026
Systematic review · 20 results
- Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.
Moiz A · Annals of internal medicine · 2026
Systematic review · 28 results
- Use of incretin receptor agonists in patients submitted to metabolic bariatric surgery - a systematic review and meta-analysis.
Santos-Pereira M · Frontiers in endocrinology · 2026
Systematic review · 10 results
- Gastroparesis induced by glucagon-like peptide-1 receptor agonists: A systematic review of clinical features, diagnosis, management, and outcomes.
Olubodun T · PloS one · 2026
Systematic review · 28 results
- Analysis of the efficacy and safety of liraglutide, semaglutide, and tirzepatide for the treatment of overweight and obesity: a systematic review and network meta-analysis.
Pałka W · Journal of endocrinological investigation · 2026
Systematic review · 22 results
- GLP-1 receptor agonists in multiple sclerosis: a systematic review of preclinical and clinical evidence.
Sajjad M · Multiple sclerosis and related disorders · 2026
Systematic review · 2 results
- GLP-1 receptor agonists in pediatric obesity and diabetes: a systematic review of efficacy, metabolic effects, and safety.
Soliman AT · Diabetes research and clinical practice · 2026
Systematic review · 18 results
- Therapeutic Effects of Glucagon-like Peptide-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: A Systematic Review.
Mahoon D · International journal of molecular sciences · 2026
Systematic review · 16 results
- Differential impact of glucagon-like peptide-1 (GLP-1) receptor agonists for weight loss in the type 2 diabetic and non-diabetic populations.
Jia IT · Surgical endoscopy · 2026
Systematic review · 16 results
- Comparative Effects of Individual Glucagon-Like Peptide-1 Receptor Agonist-Based Medications on Direct Measurement of Body Composition Among Adults With Overweight or Obesity With or Without Type 2 Diabetes: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials.
Wachiraphansakul N · Diabetes, obesity & metabolism · 2026
Systematic review · 24 results
- Efficacy of Glucagon-Like Peptide-1 Receptor Agonists for Psychological Well-Being and Depressive Symptoms: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Hung TH · Human psychopharmacology · 2026
Systematic review · 15 results
- The effects of GLP-1 receptor agonists on Alzheimer's pathophysiology: A systematic review.
Corcoran E · Molecular and cellular neurosciences · 2026
Systematic review · 7 results
- Effect of Glucagon-Like-Peptide-1 Receptor Agonists (GLP-1 RA) on Neuropsychiatric Outcomes: A Systematic Review and Meta-Analysis.
Choudhury I · Clinical therapeutics · 2026
Systematic review · 29 results
- Association of Glucagon-Like Peptide-1 Receptor Agonists and Suicidality: A Systematic Review.
Au HCT · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
Systematic review · 5 results
- Interventions for prediabetes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials.
Veronese N · Diabetes & metabolic syndrome · 2025
Systematic review · 5 results
- Effect of Calorie Restricted Diet Versus Liraglutide on Intrapancreatic Fat Deposition in People With Obesity: A Pilot Study.
Cheng H · Obesity (Silver Spring, Md.) · 2026
Non-randomized trial · 19 results
- Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment.
von Scholten BJ · Diabetic medicine : a journal of the British Diabetic Association · 2015
Non-randomized trial · 10 results
- Effect of liraglutide on body weight and microvascular function in non-diabetic overweight women with coronary microvascular dysfunction.
Suhrs HE · International journal of cardiology · 2019
Non-randomized trial · 6 results
- Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide.
Flint A · British journal of clinical pharmacology · 2010
Non-randomized trial · 6 results
- An open-label, parallel group study investigating the effects of age and gender on the pharmacokinetics of the once-daily glucagon-like peptide-1 analogue liraglutide.
Damholt B · Journal of clinical pharmacology · 2006
Non-randomized trial · 6 results
- Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes.
von Scholten BJ · Journal of diabetes and its complications · 2015
Non-randomized trial · 4 results
- Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy.
Irace C · Cardiovascular diabetology · 2018
Non-randomized trial · 2 results
- Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.
DeVries JH · Diabetes care · 2012
Non-randomized trial · 11 results
- Liraglutide reduces the body weight and waist circumference in Chinese overweight and obese type 2 diabetic patients.
Feng P · Acta pharmacologica Sinica · 2015
Non-randomized trial · 11 results
- Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Rizzo M · Cardiovascular diabetology · 2016
Non-randomized trial · 10 results
- Effect of liraglutide on cardiometabolic profile and on bioelectrical impedance analysis in patients with obesity and metabolic syndrome.
Freitas FPC · Scientific reports · 2023
Non-randomized trial · 6 results
- Evaluation of weight loss and metabolic changes in diabetic patients treated with liraglutide, effect of RS 6923761 gene variant of glucagon-like peptide 1 receptor.
de Luis DA · Journal of diabetes and its complications · 2015
Non-randomized trial · 10 results
- Liraglutide Does Not Adversely Impact Fat-Free Mass Loss.
Grannell A · Obesity (Silver Spring, Md.) · 2021
Non-randomized trial · 6 results